Riskpilot← Back to searchSign inGet full accessT&W miLINQ ApS
APSActiveCVR 42547905Nymøllevej 6Other information technology and computer service activities · NACE 6290Est. 20215 employees
Revenue 2025
DKK -916K
+50% vs 2024
EBITDA margin
665.4%
-23% vs 2024
Equity ratio
80.2%
Financial strength
Net profit 2025
DKK -5,3M
-38% vs 2024
| Revenue | DKK -916K | +50% |
| EBITDA | DKK -6,1M | -23% |
| Net profit | DKK -5,3M | -38% |
| Total assets | DKK 9,8M | +67% |
| Equity | DKK 7,9M | +42% |
| Employees | 5 | — |
Legal name
T&W miLINQ ApS
CVR number
42547905
Legal form
Anpartsselskab
NACE code
6290 · Other information technology and computer service activities
Founded
12. juli 2021
Share capital
DKK 154.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør eller af den samlede direktion.
Company purpose
Selskabets formål er at drive virksomhed med udvikling og salg af IT-løsninger og anden virksomhed relateret hertil, samt enhver aktivitet der efter direktionens skøn står i forbindelse hermed.
Address
Nymøllevej 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | -13 | 160 | -611 | -916 |
| Staff expenses | -0 | -2.982 | -4.353 | -5.182 |
| EBITDA | -13 | -2.823 | -4.964 | -6.098 |
| Depreciation & amort. | -0 | -21 | -36 | -36 |
| EBIT | -13 | -2.843 | -5.000 | -6.134 |
| Net financials | 2 | 37 | 19 | 83 |
| Profit before tax | -11 | -2.806 | -4.981 | -6.051 |
| Tax | -2 | -626 | -1.130 | -731 |
| Net profit | -9 | -2.180 | -3.851 | -5.320 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1.004 | 3.610 | 5.900 | 9.842 |
| Equity | 991 | 2.812 | 5.560 | 7.891 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 13 | 796 | 340 | 1.951 |
| Total debt | 13 | 796 | 340 | 1.951 |
EBITDA margin
-609813700.0%
This company
15.8%
Market median
-3859580480% vs market
20222025
Equity ratio
80.2%
This company
38.2%
Market median
+110% vs market
20222025
Return on equity
-67.4%
This company
18.4%
Market median
-466% vs market
20222025
Net profit margin
-531979500.0%
This company
8.1%
Market median
-6567648248% vs market
20222025
Asset turnover
-0.09×
This company
1.12×
Market median
-108% vs market
20222025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20222025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-12 – 2022-09-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TE Chief Executive Officer | Chief Executive Officer | 2024 |
LN Management | Management | 2024 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 66.67–89.99% | 66.67–89.99% | 2024 | |
| Company | 25–33.32% | 25–33.32% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
T&W Medical A/S
T&W miLINQ ApS Board members of T&W miLINQ ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Evers Christensen | Chief Executive Officer | 0 companies |
| Lars Nørgaard | Management | 0 companies |